In This Section

SU2C Scientific Advisory Committee (SAC)

Phillip A. Sharp, PhD
Chairperson

Phillip A. Sharp, PhD

Institute Professor; David H. Koch Institute for Integrative Cancer Research
Massachusetts Institute of Technology
Cambridge, Massachusetts

Elizabeth H. Blackburn, PhD
Vice Chairperson

Elizabeth H. Blackburn, PhD

Morris Herzstein Professor of Biology and Physiology
University of California, San Francisco
San Francisco, California

Raymond N. DuBois, MD, PhD
Vice Chairperson

Raymond N. DuBois, MD, PhD

Professor and Dean
College of Medicine, Medical University of South Carolina
Charleston, South Carolina

Lee J. Helman, MD
Vice Chairperson

Lee J. Helman, MD

Director of Cancer Research Program
Children’s Hospital Los Angeles; Professor of Pediatrics
Keck School of Medicine of University of Southern California
Los Angeles, California

Arnold J. Levine, PhD
Vice Chairperson

Arnold J. Levine, PhD

Professor
Institute for Advanced Study and Cancer Institute of New Jersey
Princeton, New Jersey

William G. Nelson, MD, PhD
Vice Chairperson

William G. Nelson, MD, PhD

Director
Sidney Kimmel Comprehensive Cancer Center; Johns Hopkins University
Baltimore, Maryland

Julian Adams, PhD
Member

Julian Adams, PhD

Chairman and Chief Executive Officer
Gamida Cell
Cambridge, Massachusetts

Alan Bernstein, PhD
Member

Alan Bernstein, PhD

President and CEO
Canadian Institute for Advanced Research (CIFAR)
Toronto, Ontario, Canada

Carlos L. Arteaga, MD
Member

Carlos L. Arteaga, MD

Director and Associate Dean of 
Oncology Programs
UT Southwestern Harold C. Simmons Cancer Center
Dallas, Texas

John D. Carpten, PhD
Member

John D. Carpten, PhD

Director of the Institute of Translational Genomics
Keck School of Medicine of University of Southern California
Los Angeles, California

Judy E. Garber, MD, MPH
Member

Judy E. Garber, MD, MPH

Director, Center for Cancer Genetics and Prevention
Dana-Faber Cancer Institute
Boston, Massachusetts

Richard B. Gaynor, MD
Member

Richard B. Gaynor, MD

President of Research & Development
Neon Therapeutics
Indianapolis, Indiana

Nancy F. Goodman, JD
Advocate

Nancy F. Goodman, JD

Founder and Executive Director
Kids v. Cancer
Washington, District of Columbia

William N. Hait, MD, PhD, FAACR
Member

William N. Hait, MD, PhD, FAACR

Global Head of External Innovation
Janssen, Pharmaceutical Companies of
Johnson & Johnson
Raritan, New Jersey

William G. Kaelin Jr., MD
Member

William G. Kaelin Jr., MD

Professor of Medicine
Dana-Farber Cancer Institute
Boston, Massachusetts

Michael B. Kastan, MD, PhD
Member

Michael B. Kastan, MD, PhD

Executive Director
Duke Cancer Institute
Durham, North Carolina

Guillermina (Gigi) Lozano, PhD
Member

Guillermina (Gigi) Lozano, PhD

Chairman and Professor, Department of Genetics
The University of Texas MD Anderson Cancer Center
Houston, Texas

Tak W. Mak, PhD
Member

Tak W. Mak, PhD

Chief Scientific Officer
Campbell Family Institute for Breast Cancer Research
Toronto, Ontario, Canada

Andre Nussenzweig, PhD
Member

Andre Nussenzweig, PhD

Chief, Laboratory of Genome Integrity
NIH Distinguished Investigator
Center for Cancer Research National Cancer Institute
Bethesda, Maryland

Laurie H. Glimcher, MD
Member

Laurie H. Glimcher, MD

President and CEO
Dana-Farber Cancer Institute
Boston, Massachusetts

Cecil B. Pickett, PhD
Member

Cecil B. Pickett, PhD

President, Retired
Biogen Idec
Cambridge, Massachusetts

Roderic I. Pettigrew, PhD, MD
Member

Roderic I. Pettigrew, PhD, MD

CEO of Engineering Health (EnHealth) and Executive Dean for Engineering Medicine (EnMed)
Texas A&M University
Houston, Texas

Laura K. Shawver, PhD
Member

Laura K. Shawver, PhD

La Jolla, California

Arlene H. Sharpe, MD, PhD
Member

Arlene H. Sharpe, MD, PhD

George Fabyan Professor of Comparative Pathology
Co-Director, Harvard Institute of Translational Immunology
Co-Director, Evergrande Center for Immunologic Diseases
Harvard Medical School
Boston, Massachusetts

Ellen V. Sigal, PhD
Advocate

Ellen V. Sigal, PhD

Chairperson and Founder
Friends of Cancer Research (Friends)
Washington, District of Columbia

David A. Tuveson MD, PhD
Member

David A. Tuveson MD, PhD

Chief Scientist of the Lustgarten Foundation
Director, Cold Spring Harbor Laboratory Cancer Center
Cold Spring Harbor, New York